
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
DnaJB6 CRISPR/Cas9 KO Plasmid (h) | sc-404227 | 20 µg | $397.00 |
DNAJB6 encodes DnaJB6, a member of the Hsp40/DnaJ co-chaperone family that cooperates with Hsp70 to regulate protein folding, triage, and proteostasis under basal and stress conditions. DnaJB6 is implicated in suppressing aggregation of misfolded proteins and contributes to cytoskeletal organization, chaperone-assisted quality control, and stress-responsive signaling that influence cellular homeostasis. Perturbation of DNAJB6 function has been linked to disorders characterized by protein aggregation and muscle pathology, including limb-girdle muscular dystrophy, and is also studied in the context of neurodegeneration-relevant proteotoxic stress. These biology connections make DNAJB6 a useful node for dissecting pathways that govern aggregation, chaperone networks, and cellular resilience to misfolded proteins.
DnaJB6 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the DNAJB6 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the DNAJB6 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the DNAJB6 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish DnaJB6 protein expression.
This CRISPR knockout system enables efficient generation of DNAJB6-deficient cell models for investigation of DnaJB6 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.